OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

YMAB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Y-mAbs Therapeutics (YMAB) Earnings Date & Reports

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

YMAB is expected to report earnings to rise 118.33% to -26 cents per share on August 07

Y-mAbs Therapeutics YMAB Stock Earnings Reports

Q2'25

Est.

$-0.26

Q1'25

Beat

by $0.07

Q4'24

Missed

by $0.03

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.09

The last earnings report on May 13 showed earnings per share of -11 cents, beating the estimate of -19 cents. With 25.80K shares outstanding, the current market capitalization sits at 231.46M.

View a ticker or compare two or three

Compare

YMAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For YMAB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for YMAB (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

230 Park Avenue

Phone

+1 646 885-8505

Employees

100

Web

https://www.ymabs.com